SCHEMBL7097848

SCHEMBL7097848

CSc1ccccc1-c1ccc(NC(=O)N(Cc2cccc(-c3noc(C)n3)c2)c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
TP53 P04637 3/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 5/20 0.39
HTT P42858 3/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 2/20 0.38
NPC1 O15118 2/20 0.38
GAA P10253 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
DAO P14920 1/20 0.37
HTR1D P28221 2/20 0.37
HTR1B P28222 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7098774 0.87 PDE4A (0.46) MAPTTP53POLBLMNAHTT
SCHEMBL7096847 0.86 MAPT (0.40) MAPTTP53POLBLMNAHTT
SCHEMBL7097280 0.85 MAPT (0.45) MAPTTP53POLBLMNAHTT
SCHEMBL7096610 0.83 PDE4A (0.42) MAPTTP53POLBLMNAHTT
SCHEMBL7072131 0.78 LTB4R2 (0.43) MAPTTP53POLBLMNAHPGD
SCHEMBL7084905 0.75 DAO (0.39) MAPTTP53POLBLMNANPC1
SCHEMBL7084908 0.75 ABHD6 (0.39) TP53LMNAHTTMAPK1NPC1
SCHEMBL7084912 0.74 TP53 (0.39) MAPTTP53HPGDMAPK1RAB9A
SCHEMBL7072083 0.74 L3MBTL1 (0.47) MAPTTP53POLBLMNAMAPK1
SCHEMBL7098174 0.73 LMNA (0.42) MAPTTP53POLBLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171579-A1 Urethane derivatives MERCK PATENT GMBH (DE) 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171579-A1 Urethane derivatives UTS2R, PLAUR, IL1A MAPT 4210/4885TP53 4080/4885POLB 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.